Your browser doesn't support javascript.
[Thoughts and practice on the treatment of severe and critical new coronavirus pneumonia].
Li, H C; Ma, J; Zhang, H; Cheng, Y; Wang, X; Hu, Z W; Li, N; Deng, X R; Zhang, Y; Zheng, X Z; Yang, F; Weng, H Y; Dong, J P; Liu, J W; Wang, Y Y; Liu, X M.
  • Li HC; Division of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing 100034, China.
  • Ma J; Division of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing 100034, China.
  • Zhang H; Division of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing 100034, China.
  • Cheng Y; Division of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing 100034, China.
  • Wang X; Division of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing 100034, China.
  • Hu ZW; Division of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing 100034, China.
  • Li N; Division of Critical Care Medicine, Peking University First Hospital, Beijing 100034, China.
  • Deng XR; Division of Rheumatology, Peking University First Hospital, Beijing 100034, China.
  • Zhang Y; Division of Endocrinology, Peking University First Hospital, Beijing 100034, China.
  • Zheng XZ; Division of Nephrology, Peking University First Hospital, Beijing 100034, China.
  • Yang F; Division of Cardiology, Peking University First Hospital, Beijing 100034, China.
  • Weng HY; Division of Cardiology, Peking University First Hospital, Beijing 100034, China.
  • Dong JP; Division of Digestive Disease, Peking University First Hospital, Beijing 100034, China.
  • Liu JW; Division of Thoracic Surgery, Peking University First Hospital, Beijing 100034, China.
  • Wang YY; Division of Thoracic Surgery, Peking University First Hospital, Beijing 100034, China.
  • Liu XM; Division of Geriatrics, Peking University First Hospital, Beijing 100034, China.
Zhonghua Jie He He Hu Xi Za Zhi ; 43(5): 396-400, 2020 May 12.
Article in Chinese | MEDLINE | ID: covidwho-9384
ABSTRACT
Severe and critical coronavirus pneumonia 2019 (COVID-19) often occurs in elder patients with multiple comorbidities, and severe hypoxemia events constitute a key factor for the deterioration of some cases. The critical type of COVID-19 could progress into acute respiratory distress syndrome and multi-organ dysfunction, which are the major causes of death. Early non-invasive ventilation (NIV) treatment of possible pathophysiological abnormalities is helpful to improve prognosis. Close monitoring of oxygenation, reducing patients' oxygen consumption, active psychological intervention, and rapid handling of severe hypoxemia events are the key factors for successful NIV treatment. In addition, active adjuvant therapies such as correcting coagulation dysfunction, providing proper nutritional support, accurate volume control, and safe individualized blood glucose monitoring are of great significance.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia / Pneumonia, Viral / Coronavirus Infections / Pandemics Type of study: Observational study / Prognostic study Topics: Long Covid Limits: Aged / Humans Language: Chinese Journal: Zhonghua Jie He He Hu Xi Za Zhi Year: 2020 Document Type: Article Affiliation country: Cma.j.cn112147-20200312-00320

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia / Pneumonia, Viral / Coronavirus Infections / Pandemics Type of study: Observational study / Prognostic study Topics: Long Covid Limits: Aged / Humans Language: Chinese Journal: Zhonghua Jie He He Hu Xi Za Zhi Year: 2020 Document Type: Article Affiliation country: Cma.j.cn112147-20200312-00320